Literature DB >> 487604

Plasma trypsin in chronic pancreatitis and pancreatic adenocarcinoma.

T E Adrian, H S Besterman, C N Mallinson, A Pera, M R Redshaw, T P Wood, S R Bloom.   

Abstract

We have used a simple and precise radioimmunoassay to measure trypsin in human plasma. Fasting plasma trypsin concentrations were extremely low in patients with chronic pancreatitis with steatorrhoea (5 +/- 2 ng/ml) when compared to healthy controls (86 +/- 7 ng/ml, p less than 0.001). In patients with chronic pancreatitis but no steatorrhoea basal plasma trypsin levels were similar to those of the normal controls (99 +/- 25 ng/ml). A small but significant postprandial rise in plasma trypsin concentrations was observed in normal subjects (mean increment 15 +/- 4%, p less than 0.005, paired t test) but was absent in patients with chronic pancreatitis with steatorrhoea. In contrast to exocrine deficient chronic pancreatitis, other malabsorptive conditions associated with steatorrhoea (active coeliac disease and acute tropical sprue) demonstrated mean fasting trypsin concentrations similar to controls. Patients with adenocarcinoma of the pancreas had basal trypsin concentrations similar to healthy subjects as did patients with adenocarcinoma of the stomach, colon, rectum, brochus, and breast. In some cases measurement of plasma trypsin may be of help in the differential diagnosis of steatorrhoea.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 487604     DOI: 10.1016/0009-8981(79)90417-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  16 in total

1.  Serum trypsinogen.

Authors:  A Andriulli; G Masoero
Journal:  Dig Dis Sci       Date:  1984-05       Impact factor: 3.199

2.  Predictive value of a low serum trypsinogen.

Authors:  W M Steinberg; S S Goldstein; N D Davis; K K Anderson; J M Shamma'a
Journal:  Dig Dis Sci       Date:  1985-06       Impact factor: 3.199

3.  Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.

Authors:  Shalini Makawita; Chris Smith; Ihor Batruch; Yingye Zheng; Felix Rückert; Robert Grützmann; Christian Pilarsky; Steven Gallinger; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2011-06-07       Impact factor: 5.911

4.  Serum trypsinogen in diagnosis of chronic pancreatitis.

Authors:  W M Steinberg; K K Anderson
Journal:  Dig Dis Sci       Date:  1984-11       Impact factor: 3.199

5.  Clinical value of serum immunoreactive trypsin concentration.

Authors:  W S Ruddell; C J Mitchell; I Hamilton; J P Leek; J Kelleher
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-28

6.  Diagnostic accuracy of serum cationic trypsinogen estimation for pancreatic diseases.

Authors:  G Masoero; A Andriulli; A Bianco; V Benitti; M Marchetto; M De La Pierre
Journal:  Dig Dis Sci       Date:  1982-12       Impact factor: 3.199

7.  Serum elastase 1 in chronic pancreatic disease.

Authors:  G Del Favero; C Fabris; M Plebani; A Panucci; A Piccoli; L Perobelli; A Burlina; R Naccarato
Journal:  Klin Wochenschr       Date:  1985-07-01

8.  Increased interdigestive pancreatic trypsin secretion in alcoholic pancreatic disease.

Authors:  W R Brugge; C A Burke; D L Brand; W Y Chey
Journal:  Dig Dis Sci       Date:  1985-05       Impact factor: 3.199

9.  [Dissociation of serum kinetics of amylase and trypsin following stimulation with secretin and pancreozymin].

Authors:  W Bieger; G Trischler; P Malfertheiner
Journal:  Klin Wochenschr       Date:  1982-11-02

10.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.